1. Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines

   • Mark H. Einstein

   Review 22 December 2007 Pages: 443 - 451

   

2. A novel murine model of allogeneic vaccination against prostate cancer

   • M.-C. Labarthe
   • P. Theocharous
   • M. A. Whelan

   Original Article 06 September 2007 Pages: 453 - 465

   

3. Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes

   • Jan Dörrie
   • Niels Schaft
   • Gerold Schuler

   Original Article 02 September 2007 Pages: 467 - 477

   

4. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor

   • Cheng-Chi Liu
   • Yu-Shan Wang
   • Rea-Min Chu

   Original Article 21 August 2007 Pages: 479 - 491

   

5. Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma

   • Paul Neeson
   • Zhen Kun Pan
   • Yvonne Paterson

   Original Article 18 September 2007 Pages: 493 - 505

   

6. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis

   • Susanna Lewēn
   • He Zhou
   • Yunping Luo

   Original Article 05 September 2007 Pages: 507 - 515

   

7. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid

   • Weihsu Chen
   • Weili Yan
   • Leaf Huang

   Original Article 28 August 2007 Pages: 517 - 530

   

8. Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

   • Francoise Bouet-Toussaint
   • Florian Cabillic
   • Véronique Catros

   Original Article 01 September 2007 Pages: 531 - 539

   

9. CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow

   • Irma Airoldi
   • Claudia Cocco
   • Vito Pistoia

   Original Article 05 September 2007 Pages: 541 - 548

   

10. CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged

    • Sanjay Sharma
    • Ana Lucia Dominguez
    • Joseph Lustgarten

    Original Article 08 September 2007 Pages: 549 - 561

    

11. Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8⁺CD62L^hi cells and results in superior anti-tumor activity in a tolerogenic murine model

    • C. Marcela Díaz-Montero
    • Sabry El Naggar
    • Mohamed L. Salem

    Original Article 28 August 2007 Pages: 563 - 572

    

12. The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity

    • Haley W. Sinn
    • Bennett D. Elzey
    • Timothy L. Ratliff

    Original Article 05 September 2007 Pages: 573 - 579

    

13. Saccharomyces cerevisiae, the Baker’s Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice

    • Mamdooh Ghoneum
    • Nariman K. Badr El-Din
    • Lucilene Tolentino

    Original Article 22 September 2007 Pages: 581 - 592

    

14. Progress in vaccination against cancer-7: report of the meeting in Stockholm, September 10–11, 2007

    • R. Kiessling
    • A. De Geer
    • S. Vertuani

    Meeting Report 20 November 2007 Pages: 593 - 599